We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Generics Safe Harbor Question Could Derail Biosimilars

Law360, New York (August 21, 2012, 10:13 PM EDT) -- Biologic drug sponsors may have a powerful weapon to block competition from cheaper biosimilars, experts say, if they can successfully argue that the generic drug law's safe harbor from patent infringement...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.